Have You Heard Of Biomarker Testing?

HOSTS: Hildy Grossman with Jordan Rich
GUESTS: Anthony Sireci, MD, and Hilary Hammell, MD

In this podcast, we ask the question, “Along with an accurate cancer diagnosis,
why is comprehensive biomarker testing so important?” Our guest, Dr. Anthony
Sireci, Vice President of Clinical Biomarker and Diagnostics Development at
Loxo@Lilly, has devoted his career to biomarker testing and development. He
shares his interest in precision medicine and talks about what inspired him to get
involved in this field. He helps us understand why comprehensive biomarker
testing is so important when considering treatment options for cancers, including
non-small cell lung cancer (NSCLC). Our other guest, Hilary Hammell, is a physician
herself, and has been diagnosed with advanced stage lung cancer. She shares her
own experience about learning she has the RET positive biomarker. She adds that
knowing her own biomarker guided her to a treatment that helped to “save her
life.” This episode is important for understanding how precision medicine works,
how it’s different from other current treatments, and how patients and their
families can address comprehensive biomarker testing with their physician. With
this fascinating and informative conversation, the question remains how to
increase patients’ access to biomarker testing.